Literature DB >> 15837711

Functional re-expression of CCR7 on CMV-specific CD8+ T cells upon antigenic stimulation.

Ester M M van Leeuwen1, Jaap D van Buul, Ester B M Remmerswaal, Peter L Hordijk, Ineke J M ten Berge, Rene A W van Lier.   

Abstract

During latency circulating human cytomegalovirus (CMV)-specific CD8(+) T cells do not express the chemokine receptor CCR7. We here show that antigen-specific stimulation in vitro with the specific CMV-peptide in combination with CMV-antigen, IL-2 or IL-21 induced re-expression of CCR7 on CMV-specific CD8(+) T cells. Although IL-15 induced strong proliferation of peptide-pulsed CMV-specific CD8(+) T cells, these cells did not re-express CCR7. CMV-specific cells that re-expressed CCR7 also expressed CD62L and were able to react to specific chemokine stimulation with changes in the cytoskeleton. In addition, activated CMV-specific cells specifically migrated towards a chemokine gradient in a transwell assay, with and without an endothelial cell monolayer. We conclude that antigenic stimulation induced functional re-expression of CCR7 which suggests that the migratory properties of virus-primed T cells are flexible and depend on the presence or absence of antigen and cytokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837711     DOI: 10.1093/intimm/dxh251

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

1.  Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.

Authors:  B Choufi; J Trauet; S Thiant; M Labalette; I Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

2.  TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.

Authors:  Nina Chi Sabins; Olesya Chornoguz; Karen Leander; Fred Kaplan; Richard Carter; Michelle Kinder; Kurtis Bachman; Raluca Verona; Shixue Shen; Vipul Bhargava; Sandra Santulli-Marotto
Journal:  J Immunol       Date:  2017-11-10       Impact factor: 5.422

3.  IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice.

Authors:  Haoli Jin; Michiko K Oyoshi; Yi Le; Teresa Bianchi; Suresh Koduru; Clinton B Mathias; Lalit Kumar; Séverine Le Bras; Deborah Young; Mary Collins; Michael J Grusby; Joerg Wenzel; Thomas Bieber; Marianne Boes; Leslie E Silberstein; Hans C Oettgen; Raif S Geha
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

4.  Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.

Authors:  Sascha Ansén; Marcus O Butler; Alla Berezovskaya; Andrew P Murray; Kristen Stevenson; Lee M Nadler; Naoto Hirano
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 5.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

Review 6.  Dynamics of T cell memory in human cytomegalovirus infection.

Authors:  Edward C P Waller; Elizabeth Day; J G Patrick Sissons; Mark R Wills
Journal:  Med Microbiol Immunol       Date:  2008-02-27       Impact factor: 3.402

Review 7.  IL-21: a pleiotropic cytokine with potential applications in oncology.

Authors:  Michela Croce; Valentina Rigo; Silvano Ferrini
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

8.  Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Kirstin M Heutinck; Anja Ten Brinke; Mariet C W Feltkamp; Neelke C van der Weerd; Karlijn A M I van der Pant; Frederike J Bemelman; René A W van Lier; Ineke J M Ten Berge
Journal:  PLoS Pathog       Date:  2016-10-10       Impact factor: 6.823

9.  Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.

Authors:  Halvor Rollag; Thor Ueland; Anders Asberg; Anders Hartmann; Alan G Jardine; Atul Humar; Mark D Pescovitz; Angelo A Bignamini; Pål Aukrust
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

10.  How to define biomarkers of human T cell aging and immunocompetence?

Authors:  Dietmar Herndler-Brandstetter; Harumichi Ishigame; Richard A Flavell
Journal:  Front Immunol       Date:  2013-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.